• 1. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 2. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 3. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
• 4. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
• 5. An integrated droplet-digital microfluidic system for on-demand droplet creation, mixing, incubation, and sorting?
  Lab Chip, 2019,19, 524-535

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzimidazoles Benzimidazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzimidazoles

Recent Advances in the Study of Ethyl 1H-1,3-Benzodiazole-5-carboxylate (CAS: 58842-61-8) and Its Applications in Chemical Biology and Pharmaceutical Research

Ethyl 1H-1,3-benzodiazole-5-carboxylate (CAS: 58842-61-8) is a heterocyclic compound that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound, characterized by its benzodiazole core and ester functional group, serves as a key intermediate in the synthesis of various bioactive molecules. Recent studies have explored its potential as a building block for drug development, particularly in the design of kinase inhibitors, antimicrobial agents, and fluorescent probes. This research brief aims to summarize the latest findings related to this compound, highlighting its synthetic utility, biological activities, and emerging applications.

One of the most notable advancements in the study of ethyl 1H-1,3-benzodiazole-5-carboxylate is its role in the synthesis of kinase inhibitors. Kinases are critical targets in cancer therapy, and researchers have leveraged the benzodiazole scaffold to develop potent and selective inhibitors. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of this compound exhibit strong inhibitory activity against cyclin-dependent kinases (CDKs), which are implicated in cell cycle regulation. The study reported a novel series of compounds synthesized from ethyl 1H-1,3-benzodiazole-5-carboxylate, showing promising antiproliferative effects in vitro and in vivo. These findings underscore the compound's potential as a starting point for anticancer drug discovery.

In addition to its applications in oncology, ethyl 1H-1,3-benzodiazole-5-carboxylate has been investigated for its antimicrobial properties. A recent study in Bioorganic & Medicinal Chemistry Letters highlighted the compound's utility in designing new antibacterial agents. Researchers modified the benzodiazole core to enhance its interaction with bacterial enzymes, resulting in derivatives with potent activity against methicillin-resistant Staphylococcus aureus (MRSA). The study also explored the structure-activity relationship (SAR) of these derivatives, providing valuable insights for future drug optimization. These results suggest that ethyl 1H-1,3-benzodiazole-5-carboxylate could play a pivotal role in addressing the growing challenge of antibiotic resistance.

Beyond its therapeutic potential, ethyl 1H-1,3-benzodiazole-5-carboxylate has also found applications in chemical biology as a fluorescent probe. Its benzodiazole core exhibits unique photophysical properties, making it suitable for imaging and sensing applications. A 2022 study in ACS Chemical Biology reported the development of a benzodiazole-based fluorescent probe derived from this compound, which was used to detect reactive oxygen species (ROS) in live cells. The probe demonstrated high sensitivity and selectivity, enabling real-time monitoring of oxidative stress in biological systems. This innovation opens new avenues for studying cellular processes and disease mechanisms.

In conclusion, ethyl 1H-1,3-benzodiazole-5-carboxylate (CAS: 58842-61-8) continues to be a compound of great interest in chemical biology and pharmaceutical research. Its versatility as a synthetic intermediate, combined with its diverse biological activities, positions it as a valuable tool for drug discovery and development. Recent studies have expanded our understanding of its potential, from kinase inhibition and antimicrobial activity to fluorescent probing. As research progresses, this compound is likely to play an increasingly important role in addressing unmet medical needs and advancing scientific knowledge. Future work should focus on optimizing its derivatives for clinical translation and exploring novel applications in other therapeutic areas.

• 106429-38-3(Methyl 2-amino-1h-benzimidazole-5-carboxylate)
• 106429-51-0(1H-Benzimidazole-6-carboxylicacid, 2-methyl-, methyl ester)
• 26663-77-4(1H-Benzimidazole-5-carboxylic Acid Methyl Ester)
• 24370-20-5(ethyl 2-amino-1H-1,3-benzodiazole-6-carboxylate)
• 857035-29-1(Ethyl 2-chloro-1H-benzodimidazole-6-carboxylate)
• 808744-96-9(1H-Benzimidazole-5-carboxylicacid, 2,7-dimethyl-, ethyl ester)
• 37619-25-3(methyl 1H-1,3-benzodiazole-4-carboxylate)
• 10351-79-8(Methyl 6-methyl-1H-benzo[d]imidazole-5-carboxylate)
• 167487-83-4(Ethyl 1H-benzo[d]imidazole-7-carboxylate)
• 167993-16-0(1H-Furo[3,4-f]benzimidazole-5,7-dione(9CI))